Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-17

Clinical Trial Update: Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating a novel buprenorphine induction method for individuals with opioid use disorder who use fentanyl.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Opioid Use Disorder | Phase 3 | Status: RECRUITING